Cargando…
Synthesis of an Antimicrobial Enterobactin‐Muraymycin Conjugate for Improved Activity Against Gram‐Negative Bacteria
Overcoming increasing antibiotic resistance requires the development of novel antibacterial agents that address new targets in bacterial cells. Naturally occurring nucleoside antibiotics (such as muraymycins) inhibit the bacterial membrane protein MraY, a clinically unexploited essential enzyme in p...
Autores principales: | Rohrbacher, Christian, Zscherp, Robert, Weck, Stefanie C., Klahn, Philipp, Ducho, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107792/ https://www.ncbi.nlm.nih.gov/pubmed/36222466 http://dx.doi.org/10.1002/chem.202202408 |
Ejemplares similares
-
Merging Natural Products: Muraymycin–Sansanmycin Hybrid Structures as Novel Scaffolds for Potential Antibacterial Agents
por: Niro, Giuliana, et al.
Publicado: (2020) -
Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit
por: Heib, Anna, et al.
Publicado: (2019) -
Aminoribosylated Analogues of Muraymycin Nucleoside Antibiotics
por: Wiegmann, Daniel, et al.
Publicado: (2018) -
Biomimetic enterobactin analogue mediates iron-uptake and cargo transport into E. coli and P. aeruginosa
por: Zscherp, Robert, et al.
Publicado: (2021) -
Analogues of Muraymycin Nucleoside Antibiotics with Epimeric Uridine-Derived Core Structures
por: Spork, Anatol P., et al.
Publicado: (2018)